Dr. Richard Amaee

With a Biochemistry PhD (Cambridge) Richard has extensive knowledge and experience working with novel and generic pharmaceutical products, including injectable vaccines and is well versed in CMC, Regulatory and Quality processes.

As Programme Manager, Richard will be responsible for the development of Stablepharma’s reformulated, fridge-free SPVX02 vaccine for Tetanus diphtheria.